# Album Artwork UI Palette V2 0.7.4 Bounded Candidate Review Postmortem

Status: the separately authorized two-item bounded development review has one complete, strictly verified
submission and its predeclared read-only descriptive analysis is complete. Phase 3 remains open because this
delta-only review did not close the already-known poor development outputs that were unchanged or not included
in the two-item review. This document is the handoff for bounded Phase 3 work toward `0.7.5`. It does not freeze
or promote a candidate, authorize Phase 4, open a fresh or protected sample, begin persistence, or authorize an
inference or ranking change without a separate one-factor `0.7.5` protocol.

Normative product direction remains `research/ALBUM_ARTWORK_UI_PALETTE_PLAN_V2.md`. Review authority and
limitations remain those of
`research/ALBUM_ARTWORK_UI_PALETTE_PROTOCOL_V2_0_7_4_CANDIDATE_REVIEW.md`.

## Bound Evidence

- Review protocol ID: `album-artwork-ui-palette-protocol-v2-0.7.4-candidate-review-1`.
- Review protocol raw SHA-256:
  `9ee26ea72dc1260a66ce5f28eaf0c667554f888890fa125831e8060649e7f60f`.
- Review version: `album-artwork-palette-v2-0.7.4-candidate-review-1.0.0`.
- Private-manifest content ID:
  `7fcabe477a5d4e9d05a5fee128ae7faea19b3cbc453f3b2a4d27df794eeec16e`.
- Private-manifest raw SHA-256:
  `fc7fcbb3a8e85bc5228728f66be15ec6d5cc39f211fa53d91b46cf35634fe3e4`.
- Submission ID: `0cd93b0ee50621d0cd7ab3780162215105db56609e9bbb4f3c00bd4060a2e753`.
- Feedback raw SHA-256:
  `6b3837a075a6a54cc8b18ddd5114b0d63d821391788697bd0c9faa9e74c18894`.
- Analysis version: `album-artwork-palette-v2-0.7.4-candidate-review-analysis-1.0.0`.
- Analysis ID: `01aa2c81c2856b10d45a8b66dee2c9f3886d1e41700d8e1ee157e0d2fff0cd7b`.
- Analysis raw SHA-256:
  `fb56d5c9331b39fb7a9dc492d684fef820d18e1117bfc08d660222fe6d005243`.
- Analysis script raw SHA-256:
  `4c5e91ced91b62eebb303d3b1dbf4cc36bd2dd38dd87fe2139fb9ef047c8c4f8`.
- Denominator: exactly two responses for exactly two manifest items, with no duplicates or omissions.

The machine-readable analysis is
`research/data/experiments/album-artwork-palette-v2-0.7.4-candidate-review/review-analysis.json`.

## Descriptive Result

| Measure | Candidate | Exact `0.7.2` control |
| --- | ---: | ---: |
| `strong` | 2 | 2 |
| `acceptable` | 0 | 0 |
| `weak-fallback` | 0 | 0 |
| `unacceptable` | 0 | 0 |
| `uncertain` | 0 | 0 |

Relative outcomes were:

| Outcome | Count |
| --- | ---: |
| candidate stronger | 0 |
| baseline stronger | 0 |
| similarly valid | 2 |
| neither acceptable | 0 |
| uncertain | 0 |

Candidate and control issue counts were both zero for `missing gradient`, `extraneous gradient`, and
`incomplete artwork identity`. Both comments were exactly the empty string. Their verbatim value and
empty-string SHA-256 `e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855`
are retained in the analysis artifact.

## Per-Item Evidence

| Source | Candidate side | Candidate quality | Control quality | Relative outcome | Candidate issues | Control issues | Comment |
| --- | --- | --- | --- | --- | --- | --- | --- |
| `development-18` | B | strong | strong | similarly valid | none | none | empty string |
| `development-21` | A | strong | strong | similarly valid | none | none | empty string |

For `development-18`, the candidate key was
`#04002a:#161439:#f5e50c:#fded9f:flat` and the exact control key was
`#31305c:#040325:#f5e50c:#fded9f:flat`.

For `development-21`, the candidate key was
`#eed0ec:#ed81b2:#510cc9:#b62bba:flat` and the exact control key was
`#df34a7:#8c1cc6:#efd2ee:#e99235:flat`.

No technical interpretations were produced. Both comments are empty, no issue was tagged, and inventing a
mechanism diagnosis would exceed the submitted evidence. The machine-readable technical-interpretation list
is therefore empty and every per-item interpretation is `null`.

## Limitation

These are two repeatedly exposed development sources selected because their closed candidate winners changed.
The result is useful only as bounded descriptive development evidence. It is not independent generalization,
population evidence, a protected-sample result, a fresh directional result, or V2 Phase 4 evidence.

The review answered only whether the two novel `0.7.4` final winners were acceptable and whether either was
visibly weaker than its exact `0.7.2` control. It did not answer whether the complete `0.7.4` selector is ready
to leave Phase 3. In particular:

- 26 of 28 fixed-panel winners remained exact `0.7.2` winners;
- already-known poor outputs among those unchanged winners were not repaired by candidate closure;
- 44 genuinely novel retained alternatives reached public slates without becoming top-one;
- the two reviewed winners do not establish quality for the remaining development roster; and
- Phase 4 would freeze this behavior rather than improve any known development failure.

The two reviewed candidates being `strong` and `similarly-valid` is positive evidence for the selected
availability mechanism. It is not evidence that all Phase 3 failure classes are closed.

## Phase Position

Work remains in **V2 Phase 3: representatives and complete joint alternatives**. The current task is still to
make good complete treatments commonly available and correctly selected on development evidence. Phase 4 is
an evaluation of a frozen deterministic candidate on a fresh directional sample; it is not an iteration or
repair stage.

Do not freeze `0.7.4` for Phase 4 merely because its two changed winners are safe. First close or explicitly
accept the already-known severe development failures. A protected or fresh sample must not be opened in the
hope that those failures improve. They cannot improve without a new Phase 3 implementation.

The baselines for the next unit are layered:

- `album-artwork-first-principles-0.7.2` remains the default extractor and development safety control;
- closed `album-artwork-first-principles-0.7.4` is the immediate Phase 3 availability and selector baseline;
- `album-artwork-first-principles-0.6.0` remains the product and promotion comparison baseline; and
- external `region-graph-0.19.0` remains the later Phase 4 blinded comparator, not a Phase 3 inference input.

## Direction For 0.7.5

Version `0.7.5` is a bounded Phase 3 known-failure closure. Its purpose is to determine why already-known poor
development outputs remain poor under the closed `0.7.4` winner and slate, select the minimum-scope repeated
failure mechanism, and evaluate exactly one corresponding change. It is not a general invitation to improve
scores, inspect arbitrary alternatives until one looks preferable, or combine architecture changes.

### 0.7.5 Prerequisite: Bound Known-Bad Roster

Before changing candidate code or freezing a mechanism protocol, the next agent must create an immutable
known-bad development roster from existing evidence. The roster must:

1. cite the original review artifact, exact source SHA-256, complete-treatment key, quality response, issue
   tags, and verbatim comment or comment hash that made the output known-bad;
2. distinguish a human-labeled failure from an agent-inferred technical interpretation;
3. transfer a prior quality label only when both source SHA-256 and complete-treatment key match the current
   `0.7.4` output;
4. mark changed or newly retained treatments as unreviewed rather than inheriting a source-level label;
5. exclude protected/fresh sources and every case known only from a filename, source ID, color name, or agent
   memory without bound evidence;
6. predeclare severity and which failures are systemic enough to block Phase 4; and
7. freeze the roster before inspecting new counterfactual mechanism output.

Source IDs, filenames, comments, issue labels, color names, and desired colors may be used to organize human
evidence and diagnostics. They may never enter candidate inference, ranking features, source branches, or
expected-output fixtures.

### Current-Domain Diagnosis

For every bound known-bad source, inspect the checked `0.7.4` complete winner and retained slate as a coupled UI
treatment. Reconstruct exact candidate custody and classify the earliest demonstrated failure:

1. **Ranking failure:** an acceptable or strong treatment is already retained, but the deterministic top-one
   is visibly weaker.
2. **Role-attribution failure:** source-connected evidence exists, but an important signature, typography,
   symbol, or repeated mark is assigned to the wrong foreground or accent role or omitted from both.
3. **Field-structure failure:** no current one-field, separate-flat-field, or single-pair gradient hypothesis
   can represent an important broad field progression.
4. **Joint-construction failure:** defensible field and role directions exist separately but do not coexist in
   a legal complete treatment.
5. **Discovery-semantic failure:** the needed family, component, progression, polarity, topology, or contrast
   evidence never reaches the widened field-retention boundary.
6. **Representative or collapse failure:** the source direction exists, but available representatives look
   invented/noisy or optional roles collapse or remain distinct incorrectly.
7. **Accepted isolated limitation:** the failure is real but non-systemic, does not violate a core product
   obligation, and is explicitly accepted rather than silently called fixed.

Do not infer a ranking problem merely because 44 novel alternatives exist. A ranking failure requires human
evidence that a retained alternative is strong while the selected top-one is weaker. Conversely, do not change
ranking to hide a slate with no acceptable treatment.

If the existing evidence cannot classify a case without seeing a new `0.7.4` treatment, predeclare the smallest
bounded diagnostic review needed to compare the current winner with at most the best source-independently
ordered retained alternative. Opening that review still requires separate explicit authorization.

### Candidate Mechanisms

The mechanism for `0.7.5` must be selected by the bound failure classification, not by which implementation is
convenient. Permitted candidates are:

#### Deterministic Ranking Correction

Choose this only when repeated known-bad cases contain reviewed strong alternatives in the current retained
slate and weaker selected winners. Preserve the complete `0.7.4` candidate domain and begin with the smallest
interpretable deterministic correction. Evaluate the complete generator-to-winner pipeline. Do not use prior
winner outputs, source IDs, filenames, review IDs, comments, issue tags, color names, or target colors as
features. Learned ranking remains optional V2 Phase 6 and is not a `0.7.5` default.

#### Role-Specific Identity Attribution

Choose this when important source-connected signature families are available but repeatedly assigned to the
wrong foreground/accent role or absent from otherwise defensible complete treatments. Derive attribution from
source geometry, repetition, polarity, component structure, local contrast, and observability. Generic
fixtures must include dark and light typography, polarity reversals, non-text objects, repeated decorative
marks, isolated details, and signature accents.

#### Multi-Hue Or Piecewise Field Structure

Choose this when important broad field progression remains unrepresentable after premature field-hypothesis
pruning has been removed. Endpoint families, sequence, topology, and region support must come from source
geometry rather than arbitrary palette-color combinations. Generic fixtures must separate broad multi-stage
transitions from hard regions, object-local ramps, stripes, fragments, and unrelated colorful objects.

#### Mechanism-Aware Joint Construction

Choose this only when custody proves that defensible field and role directions are independently available but
cannot coexist in a legal complete treatment. Keep discovery, attribution, representative availability,
construction, Pareto, guard, and slate loss separate. Joint availability grants no unconditional winner
authority. Do not combine this initially with a new field model or new role-attribution model.

#### Discovery-Semantic Follow-Up

Choose this only when custody proves that the needed source direction never reaches the selected field-retention
boundary. Possible one-factor units include smaller family bins, iterative family refinement, more components
before repetition/polarity inference, additional gradient angles or centers, denser gradient fitting, or denser
contrast sampling. Select one. Do not bundle discovery changes with ranking, role attribution, or multi-hue
fields.

#### Representative Or Collapse Follow-Up

Choose this when the known failure is specifically a noisy/invented representative or an unearned/missing role
collapse rather than field, role, discovery, or ranking. Preserve candidate availability and alter only the
demonstrated representative or collapse boundary under generic fixtures and complete-treatment review.

### Mechanism Selection Rule

Select one repeated failure class using the frozen known-bad roster. Prefer the earliest demonstrated custody
loss and the minimum architectural scope that can explain multiple severe cases. If two classes explain the
same number and severity of bound failures, prefer the earlier custody intervention; if still tied, prefer the
mechanism that preserves more current policy and candidate-domain custody. Record all other classes as deferred
diagnostics.

Do not combine deterministic ranking, role-specific attribution, multi-hue fields, joint construction,
discovery changes, or representative/collapse changes in one `0.7.5` candidate. If no single class is supported,
end `0.7.5` as a diagnostic audit and hand the selected next mechanism to a separately versioned candidate
rather than guessing.

### 0.7.5 Protocol And Implementation Boundary

After the roster and failure classification select one mechanism, create a separate
`research/ALBUM_ARTWORK_UI_PALETTE_PROTOCOL_V2_0_7_5.md` before executing candidate output. Identify the
candidate separately as `album-artwork-first-principles-0.7.5`. Bind the V2 plan, the `0.7.3` recall handoff,
the `0.7.4` closure and review postmortems, checked `0.7.4` artifacts, review feedback and analysis, known-bad
roster, generic fixtures, fixed panel, protected seals, implementation closure, runtime, and analyzer.

Keep the following unchanged unless it is the sole selected mechanism boundary:

- native source evidence and metadata-independent deterministic ordering;
- canonical output colors, complete-treatment equality, role cardinality, and gradient rendering;
- all `0.7.4` field-hypothesis recall behavior and source-lineage requirements;
- score formulas, Pareto dimensions, complete-quality guard, identity authority, and exact-overlay authority;
- 1,500 raw complete-candidate and eight-treatment public-slate bounds;
- the default `extractAlbumArtworkPaletteV2()` at `0.7.2`; and
- the prohibition on historical winner lookup, incumbent fallback, review-derived inference, and inter-version
  inference vetoes.

Refactor shared code when necessary, but do not duplicate score, Pareto, guard, identity, overlay, or slate
policy. Historical `0.7.2`, `0.7.3`, and `0.7.4` artifacts remain immutable comparison evidence and may not be
loaded by product inference.

### 0.7.5 Mechanical Gate

Before any new human review, generic fixtures and the fixed development panel must prove:

- exact live `0.7.2` control equality and unchanged default extractor;
- exact reproduction of the closed `0.7.4` baseline before the one selected mechanism boundary;
- one-factor attribution to the selected failure class;
- preservation of every unaffected treatment, obligation, guard, overlay, and required slate reservation;
- complete source-connected lineage and unchanged legality for every new treatment;
- deterministic repeated extraction and worker scheduling invariance;
- complete-candidate and public-slate bounds;
- no source ID, filename, comment, issue tag, color name, review label, or target color in inference;
- exact per-known-bad and fixed-panel winner/slate deltas against `0.7.4`, plus safety/product comparisons to
  `0.7.2` and `0.6.0`; and
- an independently recomputed analysis that identifies whether each bound known-bad failure was resolved,
  unchanged, displaced, or regressed.

Any mechanical failure blocks review and Phase 4. A mechanism that improves one named case but lacks generic
support or causes repeated regressions does not pass.

### Phase 3 Exit Gate

Phase 3 may close only after:

- every bound severe known-bad case is resolved or explicitly accepted as an isolated limitation;
- no repeated systemic failure class remains unaddressed;
- acceptable or strong complete treatments are commonly present in retained slates;
- deterministic top-one selection does not repeatedly choose a weaker treatment when a strong alternative is
  retained;
- candidate availability, role attribution, field representation, representatives, and collapse behave
  defensibly under complete-treatment review;
- a separately versioned closed candidate passes its fixed-panel mechanical gate and bounded development
  review; and
- the deterministic candidate is frozen before any new fresh sample is opened.

Perfection on every development image is not required, but known systemic failures may not be delegated to
Phase 4. Phase 4 should test independent generalization of a candidate believed ready, not discover whether
known Phase 3 defects still exist.

## Handoff For The Next Agent

The next agent should proceed in this order:

1. read the V2 plan as normative authority;
2. treat the `0.7.3` postmortem as the candidate-recall handoff;
3. treat the `0.7.4` closure artifacts as the immutable current Phase 3 baseline;
4. use this review postmortem and its bound analysis as evidence that the two changed winners are strong and
   similarly valid, not as evidence that Phase 3 is complete;
5. build and freeze the known-bad roster from existing review evidence;
6. diagnose winner-versus-slate custody and classify the earliest repeated failure;
7. select exactly one mechanism under the rule above;
8. write the `0.7.5` protocol before candidate execution;
9. implement, test, and mechanically close that one mechanism without changing the default extractor; and
10. stop before human review, Phase 4, persistence, promotion, or protected-sample access unless separately
    authorized.

Do not start by tuning a score, reviewing all 44 alternatives, implementing multiple mechanisms, or opening a
fresh sample. The first deliverable is the evidence-bound known-bad roster and failure-class decision.

## Authorization Boundary

The review analysis remains descriptive and has no independent promotion authority. This handoff authorizes
bounded Phase 3 preparation for `0.7.5`: constructing the evidence-bound known-bad roster, diagnosing the
closed `0.7.4` winner and slate, selecting one failure class, and writing the one-factor `0.7.5` protocol. It
does not authorize opening another human review, Phase 4, a fresh or protected sample, Phase 5, promotion,
persistence, default-extractor replacement, production replacement, or full-roster execution.

The next agent may implement and mechanically evaluate one `0.7.5` mechanism only after the roster,
classification, selection rule, and protocol are frozen. Human review of a resulting candidate still requires
separate explicit authorization.
